Cargando…
Potential Applications of Artificial Intelligence in Clinical Trials for Alzheimer’s Disease
Clinical trials for Alzheimer’s disease (AD) face multiple challenges, such as the high screen failure rate and the even allocation of heterogeneous participants. Artificial intelligence (AI), which has become a potent tool of modern science with the expansion in the volume, variety, and velocity of...
Autores principales: | Seo, Younghoon, Jang, Hyemin, Lee, Hyejoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879055/ https://www.ncbi.nlm.nih.gov/pubmed/35207561 http://dx.doi.org/10.3390/life12020275 |
Ejemplares similares
-
The Application of Artificial Intelligence in the Genetic Study of Alzheimer’s Disease
por: Mishra, Rohan, et al.
Publicado: (2020) -
Predicting conversion of brain β-amyloid positivity in amyloid-negative individuals
por: Park, Chae Jung, et al.
Publicado: (2022) -
Prediction of tau accumulation in prodromal Alzheimer’s disease using an ensemble machine learning approach
por: Kim, Jaeho, et al.
Publicado: (2021) -
Artificial Intelligence for Alzheimer’s Disease: Promise or Challenge?
por: Fabrizio, Carlo, et al.
Publicado: (2021) -
Artificial Intelligence for Anterior Segment Diseases: A Review of Potential Developments and Clinical Applications
por: Xu, Zhe, et al.
Publicado: (2023)